Laboratorio Reig Jofre's revenue for the
three
months ended in Sep. 2024 was €80.3 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €331.8 Mil.
Laboratorio Reig Jofre's Revenue per Share for the
three
months ended in Sep. 2024 was €1.00.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €4.18.
Warning Sign:
Laboratorio Reig Jofre SA revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Laboratorio Reig Jofre was 3.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 10.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 13.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Laboratorio Reig Jofre's highest 3-Year average Revenue per Share Growth Rate was 153.10% per year. The lowest was -54.90% per year. And the median was 5.10% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Laboratorio Reig Jofre's Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Reig Jofre's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Revenue distribution charts can be found below:
* The bar in red indicates where Laboratorio Reig Jofre's Revenue falls into.
Laboratorio Reig Jofre Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €331.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Laboratorio Reig Jofre Revenue Related Terms
Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XMAD:RJF has been successfully added to your 